100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached 4.6 TrustPilot
logo-home
Exam (elaborations)

NR 567/ NR567 FINAL Exam (Latest 2026/ 2027) Advanced Pharmacology for the AGACNP | Q/A | Grade A | Chamberlain

Rating
-
Sold
-
Pages
33
Grade
A+
Uploaded on
06-01-2026
Written in
2025/2026

This document contains verified questions and answers for the NR 567 Final Exam in Advanced Pharmacology for the AGACNP program at Chamberlain University. It comprehensively covers advanced pharmacokinetics and pharmacodynamics, drug classes, therapeutic decision-making, medication safety, and management of complex adult and acute care conditions. Fully updated for the 2026/2027 academic year, this resource supports thorough review and confident final exam preparation. NR 567/ NR567 FINAL Exam (Latest 2026/ 2027) Advanced Pharmacology for the AGACNP | Q/A | Grade A | ChamberlainNR 567/ NR567 FINAL Exam (Latest 2026/ 2027) Advanced Pharmacology for the AGACNP | Q/A | Grade A | ChamberlainNR 567/ NR567 FINAL Exam (Latest 2026/ 2027) Advanced Pharmacology for the AGACNP | Q/A | Grade A | ChamberlainNR 567/ NR567 FINAL Exam (Latest 2026/ 2027) Advanced Pharmacology for the AGACNP | Q/A | Grade A | ChamberlainNR 567/ NR567 FINAL Exam (Latest 2026/ 2027) Advanced Pharmacology for the AGACNP | Q/A | Grade A | ChamberlainNR 567/ NR567 FINAL Exam (Latest 2026/ 2027) Advanced Pharmacology for the AGACNP | Q/A | Grade A | ChamberlainNR 567/ NR567 FINAL Exam (Latest 2026/ 2027) Advanced Pharmacology for the AGACNP | Q/A | Grade A | ChamberlainNR 567/ NR567 FINAL Exam (Latest 2026/ 2027) Advanced Pharmacology for the AGACNP | Q/A | Grade A | ChamberlainNR 567/ NR567 FINAL Exam (Latest 2026/ 2027) Advanced Pharmacology for the AGACNP | Q/A | Grade A | ChamberlainNR 567/ NR567 FINAL Exam (Latest 2026/ 2027) Advanced Pharmacology for the AGACNP | Q/A | Grade A | ChamberlainNR 567/ NR567 FINAL Exam (Latest 2026/ 2027) Advanced Pharmacology for the AGACNP | Q/A | Grade A | ChamberlainNR 567/ NR567 FINAL Exam (Latest 2026/ 2027) Advanced Pharmacology for the AGACNP | Q/A | Grade A | ChamberlainNR 567/ NR567 FINAL Exam (Latest 2026/ 2027) Advanced Pharmacology for the AGACNP | Q/A | Grade A | ChamberlainNR 567/ NR567 FINAL Exam (Latest 2026/ 2027) Advanced Pharmacology for the AGACNP | Q/A | Grade A | ChamberlainNR 567/ NR567 FINAL Exam (Latest 2026/ 2027) Advanced Pharmacology for the AGACNP | Q/A | Grade A | ChamberlainNR 567/ NR567 FINAL Exam (Latest 2026/ 2027) Advanced Pharmacology for the AGACNP | Q/A | Grade A | ChamberlainNR 567/ NR567 FINAL Exam (Latest 2026/ 2027) Advanced Pharmacology for the AGACNP | Q/A | Grade A | ChamberlainNR 567/ NR567 FINAL Exam (Latest 2026/ 2027) Advanced Pharmacology for the AGACNP | Q/A | Grade A | ChamberlainNR 567/ NR567 FINAL Exam (Latest 2026/ 2027) Advanced Pharmacology for the AGACNP | Q/A | Grade A | ChamberlainNR 567/ NR567 FINAL Exam (Latest 2026/ 2027) Advanced Pharmacology for the AGACNP | Q/A | Grade A | ChamberlainNR 567/ NR567 FINAL Exam (Latest 2026/ 2027) Advanced Pharmacology for the AGACNP | Q/A | Grade A | ChamberlainNR 567/ NR567 FINAL Exam (Latest 2026/ 2027) Advanced Pharmacology for the AGACNP | Q/A | Grade A | ChamberlainNR 567/ NR567 FINAL Exam (Latest 2026/ 2027) Advanced Pharmacology for the AGACNP | Q/A | Grade A | ChamberlainNR 567/ NR567 FINAL Exam (Latest 2026/ 2027) Advanced Pharmacology for the AGACNP | Q/A | Grade A | ChamberlainNR 567/ NR567 FINAL Exam (Latest 2026/ 2027) Advanced Pharmacology for the AGACNP | Q/A | Grade A | ChamberlainNR 567/ NR567 FINAL Exam (Latest 2026/ 2027) Advanced Pharmacology for the AGACNP | Q/A | Grade A | ChamberlainNR 567/ NR567 FINAL Exam (Latest 2026/ 2027) Advanced Pharmacology for the AGACNP | Q/A | Grade A | ChamberlainNR 567/ NR567 FINAL Exam (Latest 2026/ 2027) Advanced Pharmacology for the AGACNP | Q/A | Grade A | ChamberlainNR 567/ NR567 FINAL Exam (Latest 2026/ 2027) Advanced Pharmacology for the AGACNP | Q/A | Grade A | ChamberlainNR 567/ NR567 FINAL Exam (Latest 2026/ 2027) Advanced Pharmacology for the AGACNP | Q/A | Grade A | Chamberlain

Show more Read less











Whoops! We can’t load your doc right now. Try again or contact support.

Document information

Uploaded on
January 6, 2026
Number of pages
33
Written in
2025/2026
Type
Exam (elaborations)
Contains
Questions & answers

Content preview

1
NR 567/ NR567




NR 567/ NR567 FINAL Exam (Latest 2026/

2027) Advanced Pharmacology for the

AGACNP | Q/A | Grade A | Chamberlain




Subject: Advanced Pharmacology for the AGACNP

Source: Chamberlain University

Format: Exam Questions & Verified Answers

Description:

This document is a Final Exam V2 question bank for NR.567. It

contains multiple-choice questions with

explanations covering neurology, psychiatry, anesthesia, cardiology,

endocrinology, oncology, infectious disease, and hematology. The

resource is structured as a review tool with rationales to prepare for the

AGACNP pharmacology exam.




NR 567/ NR567

, 2
NR 567/ NR567




1. Which of the following medications should be given to patients

presenting to the emergency department (ED) with an altered level of

consciousness, seizures, or both, if a concern of Wernicke-Korsakoff

syndrome exists?

 Answer: Thiamine (Vitamin B1)

 Rationale: Wernicke-Korsakoff syndrome is caused by thiamine

(Vitamin B1) deficiency, often seen in chronic alcohol use.

Administration of thiamine is critical to prevent irreversible

neurological damage in patients presenting with altered

consciousness or seizures where this deficiency is suspected.



2. Which of the following pharmaceutical agents is not recommended

for treating methanol poisoning?

 Answer: Disulfiram (Antabuse)

 Rationale: Disulfiram is used as an aversive therapy for alcohol

dependence; it inhibits aldehyde dehydrogenase. It is not used in the

acute management of methanol poisoning. Treatment for methanol

poisoning includes ethanol or fomepizole (to inhibit alcohol

dehydrogenase), sodium bicarbonate (to correct metabolic acidosis),

and potentially dialysis.




NR 567/ NR567

, 3
NR 567/ NR567




3. Which of the following pharmaceutical agents is the preferred

antiseizure medication for a generalized seizure disorder in a 25-

year-old pregnant female?

 Answer: Levetiracetam (Keppra)

 Rationale: Valproate is a known human teratogen associated with

major congenital malformations (e.g., spina bifida) and

neurodevelopmental risks. Levetiracetam is generally considered to

have a more favorable safety profile during pregnancy compared to

other listed options like phenobarbital or topiramate.



4. Which of the following is the least preferable initial treatment of

choice for status epilepticus?

 Answer: Fosphenytoin (Cerebyx)

 Rationale: Benzodiazepines (lorazepam or diazepam) are first-line

for immediate termination of seizures in status epilepticus.

Fosphenytoin/phenytoin is a standard second-line agent for

preventing seizure recurrence after benzodiazepines have been

administered. Propofol is used for refractory cases.



5. Which of the following statements is not true?




NR 567/ NR567

, 4
NR 567/ NR567




 Answer: Sedative hypnotics can be utilized as an anticonvulsant;

zolpidem (Ambien) and lorazepam (Ativan) are excellent

options for managing seizures.

 Rationale: While benzodiazepines like lorazepam are first-line for

acute seizure management, non-benzodiazepine sedative-hypnotics

like zolpidem are not used as anticonvulsants. The other statements

about cardiovascular/respiratory depression and benzodiazepine-

induced amnesia are accurate.



6. Your patient has been taking risperidone (Risperdal) but has

developed hyperprolactinemia. Which of the following may help

manage hyperprolactinemia?

 Answer: Bromocriptine (Parlodel)

 Rationale: Bromocriptine is a dopamine agonist that directly inhibits

prolactin secretion from the pituitary gland. The other agents

(haloperidol, promethazine, chlorpromazine) are dopamine

antagonists and could worsen hyperprolactinemia.



7. A 35-year-old female with a long history of anxiety treated with

diazepam (Valium) has increasingly become fearful and anxious about

the Coronavirus pandemic and triples her daily dose. She is found



NR 567/ NR567

Get to know the seller

Seller avatar
Reputation scores are based on the amount of documents a seller has sold for a fee and the reviews they have received for those documents. There are three levels: Bronze, Silver and Gold. The better the reputation, the more your can rely on the quality of the sellers work.
DoctorKen Chamberlain College Of Nursing
View profile
Follow You need to be logged in order to follow users or courses
Sold
567
Member since
2 year
Number of followers
110
Documents
4999
Last sold
14 hours ago
All Solutions

PASS The First Time! Nursing school is demanding, and quality study materials make the difference. I provide well-organized, exam-focused nursing resources designed to help you understand key concepts, prepare efficiently, and perform confidently in assessments. These materials are carefully structured to align with nursing curricula and real exam expectations, trusted by students who want clarity, accuracy, and results. Nursing school is hard but I'm here to simplify it for you! #Study guides #Exam preparation #Test materials #Study documents #Exam resources #Test study aids #Study notes #Exam study guides #Study materials #Exam papers

Read more Read less
3.9

106 reviews

5
52
4
18
3
21
2
3
1
12

Recently viewed by you

Why students choose Stuvia

Created by fellow students, verified by reviews

Quality you can trust: written by students who passed their tests and reviewed by others who've used these notes.

Didn't get what you expected? Choose another document

No worries! You can instantly pick a different document that better fits what you're looking for.

Pay as you like, start learning right away

No subscription, no commitments. Pay the way you're used to via credit card and download your PDF document instantly.

Student with book image

“Bought, downloaded, and aced it. It really can be that simple.”

Alisha Student

Frequently asked questions